| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,049,000 | 1,586,000 | 1,552,000 | 1,342,000 | | Cost of Revenue | 673,000 | 733,000 | 794,000 | 843,000 | | | Gross Profit | 1,376,000 | 853,000 | 758,000 | 499,000 | | | Operating Expenses | | Research Development | 174,000 | 42,000 | 31,000 | 5,000 | | Selling General and Administrative | 131,000 | 155,000 | 116,000 | (62,000) | | Non Recurring |
-
|
-
|
-
| 302,000 | | Others | 182,000 | 183,000 | 201,000 | 200,000 | | | | Total Operating Expenses |
-
|
-
|
-
| 445,000 | | | | Operating Income or Loss | 889,000 | 473,000 | 410,000 | 54,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 25,000 | 9,000 | 9,000 | (67,000) | | Earnings Before Interest And Taxes | 849,000 | 482,000 | 419,000 | (13,000) | | Interest Expense | (55,000) | 23,000 | 32,000 | 29,000 | | Income Before Tax | 904,000 | 459,000 | 387,000 | (42,000) | | Income Tax Expense | 253,000 | 136,000 | 105,000 | (88,000) | | Minority Interest |
-
|
-
|
-
| (38,000) | | | | Net Income From Continuing Ops | 645,000 | 320,000 | 277,000 | 9,000 | | | Non-recurring Events | | Discontinued Operations |
-
| (14,000) |
-
| 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 156,000 | 306,000 | 277,000 | 10,000 | | Preferred Stock And Other Adjustments | 232,000 | (144,000) | (88,000) |
-
| | | Net Income Applicable To Common Shares | $388,000 | $162,000 | $189,000 | $10,000 |
|
2.03% Nasdaq 0.00%
Income Statement
